Stockscreener 앱 받기
1.12%
시간 외 거래:
Pfizer Inc 주식(PFE)의 최신 뉴스
Pfizer (NYSE:PFE) Trading Up 1.1%What's Next? - MarketBeat
Pfizer Stock Edges Higher as Oncology Wins and Pipeline Bets Fuel Optimism Amid Flat 2026 Outlook - inkl
Pfizer, Bain Must Litigate Cerevel Investors’ AbbVie Deal Suit - Bloomberg Law News
Pfizer to close South San Francisco research site (PFE:NYSE) - Seeking Alpha
Pfizer Inc. (NYSE:PFE) Tracks Healthcare Allocation In S&P 500 fund - Kalkine Media
Moderna, Pfizer Press to Toss Bayer’s Covid-Shot Patent Suits - Bloomberg Law News
Exclusive: Pfizer to shutter South S.F. research site, end Bay Area presence - San Francisco Chronicle
Is Pfizer Stock a Buy? Shares Hit Fresh High as Bulls and Bears Clash Over Valuation - TechStock²
Pfizer Inc Stock (PFE) Moved Up by 3.06% on Mar 31: Facts Behind the Movement - TradingKey
Pfizer (NYSE:PFE) Hits New 1-Year HighWhat's Next? - MarketBeat
Hemophilia B Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Pfizer, Spark Therapeutics, Sanofi, Alnylam Pharma, CSL Behring, uniQure, Novo Nordisk - Barchart.com
Pfizer stock hits 52-week high at 27.99 USD By Investing.com - Investing.com Australia
Pfizer stock hits 52-week high at 27.99 USD - Investing.com
Kidney Cancer Drugs Market to Grow by $2 Billion During 2026-2030: Pfizer, Novartis, Exelixis, Roche, Bristol Myers Squibb Company, and Bayer Lead the Industry - Yahoo Finance
Pfizer Inc. $PFE Shares Purchased by QSM Asset Management Ltd - MarketBeat
Retirement Systems of Alabama Acquires 379,870 Shares of Pfizer Inc. $PFE - MarketBeat
U.S. Rivaroxaban Market Set to Boom Rapidly by 2033 | Pfizer Inc. • Merck & Co. • Amgen Inc - openPR.com
Mn Services Vermogensbeheer B.V. Boosts Position in Pfizer Inc. $PFE - MarketBeat
Is It Time To Reconsider Pfizer (PFE) After Diverging Valuation Narratives? - simplywall.st
Director at Pfizer (NYSE: PFE) receives phantom stock unit grant - Stock Titan
Pfizer (PFE) director Shantanu Narayen receives 1,849 Phantom Stock Units as deferred pay - Stock Titan
Pfizer (PFE) director Mortimer Buckley awarded 1,386.834 phantom units - Stock Titan
Pfizer says long-awaited Lyme vaccine was effective in study - UnionLeader.com
Pfizer (NYSE:PFE) Shares Up 2.6%Time to Buy? - MarketBeat
Pfizer's Post-2025 Strategy: Acquiring New GLP-1 Therapy After Internal SetbackNews and Statistics - IndexBox
Pharma Stocks Pfizer and GSK Provide Safe Investment Options Amid Market Uncertainty: Charts - Intellectia AI
Pfizer’s CAO on Building a Data and Process Foundation for AI - WSJ
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know - Yahoo Finance
Pfizer’s (PFE) Shares Up Since Jim Cramer Said “Pass” - Insider Monkey
Travelers Vaccines Market Set to Boom Rapidly, Witnessing - openPR.com
Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline - Yahoo Finance Singapore
Esophageal Cancer Market to Grow from $1.65 Billion in 2026 to $2.37 Billion by 2030: Pfizer, Roche, Merck & Co. Dominate - GlobeNewswire Inc.
Pfizer Grant for Generic JAK Inhibitors in Rheumatology (USA) - fundsforNGOs
Pfizer (PFE) – Among the 15 Large Cap Stocks with Highest Dividends - Insider Monkey
Comirnaty Vaccine: Pfizer's Cornerstone COVID-19 Product Continues to Shape Global Health Markets in - AD HOC NEWS
Prediction: Buying Pfizer Stock Today Could Set You Up for Life - The Globe and Mail
Pfizer Developments Draw Attention Across Market Benchmarks - Kalkine Media
Advisors Management Group Inc. ADV Sells 39,525 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer Inc. (NYSE:PFE) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Pfizer Oncology Wins Raise Questions On Valuation Gap And Future Revenues - simplywall.st
Pfizer Inc. Trade Ideas — BSESOF:PFE - TradingView
Lyme disease vaccine 70 percent effective: Pfizer - FOX 8 News
Wedge Capital Management L L P NC Grows Position in Pfizer Inc. $PFE - MarketBeat
A New Lyme Disease Vaccine Is In the Works - Women's Health
PFE Stock Quote Price and Forecast - CNN
Exchange Traded Concepts LLC Sells 60,810 Shares of Pfizer Inc. $PFE - MarketBeat
Pfizer (NYSE:PFE) Trading Down 2%Here's Why - MarketBeat
PFEPfizer Inc Stock Price and Quote - Finviz
Pfizer Options Spot-On: On March 27th, 99,614 Contracts Were Traded, With 2.42 Million Open Interest - Moomoo
Pfizer Inc. stock underperforms Friday when compared to competitors - MarketWatch
Pfizer: Why Wall Street Habitually Overestimates Target Price (NYSE:PFE) - Seeking Alpha
Jim Cramer on Pfizer: “I Just Need to Know Their Product Flow Better” - Insider Monkey
Spotting the Signs of ATTR-CM: Latest Data Reveals Opportunities for More Timely Detection - Pfizer
Vanguard reports 0 Pfizer shares after realignment (NYSE: PFE) - Stock Titan
Bispecific T-Cell Engagers Market Insights Report (2026-2030) Featuring Strategic Analysis of Pfizer, Johnson & Johnson, Roche, AbbVie, Sanofi and Other Key Players - Yahoo Finance
Why Pfizer Remains A Strong Buy In 2026 (NYSE:PFE) - Seeking Alpha
Jim Cramer Broke Down 5 Stocks Including Pharma Plays for Rising Oil - Insider Monkey
Is Pfizer’s Late‑Stage Lyme Vaccine Progress Reshaping the Investment Case for PFE? - simplywall.st
Pfizer Inc. Shs Unsponsored Canadian Depository Receipt Hedged Cash Flow – FWB:PFE1 - TradingView
Local Anesthesia Drugs Market Is Going to Boom Rapidly | Septodont, Pfizer Inc., Pacira BioSciences, Inc. - openPR.com
Pfizer Inc. $PFE Shares Acquired by Fort Washington Investment Advisors Inc. OH - MarketBeat
Pfizer Inc (PFE): Our Calculation of Intrinsic Value - The Acquirer's Multiple
Guggenheim Sees Favorable Risk-Reward for Pfizer (PFE) Ahead of Phase 3 Data - Insider Monkey
Why the Market Dipped But Pfizer (PFE) Gained Today - finance.yahoo.com
Pfizer Options Spot-On: On March 26th, 100.37K Contracts Were Traded, With 2.39 Million Open Interest - Moomoo
Federal Circuit schedules oral argument in Enanta’s patent case against Pfizer - investing.com
Income Investors Face a Hard Truth About Pfizer’s Payout Safety - Yahoo Finance
Pfizer Lyme Vaccine Readout Adds New Angle To Valuation Debate - simplywall.st
4.14%
자본화:
|
볼륨(24시간):